A detailed history of Lbmc Investment Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Lbmc Investment Advisors, LLC holds 1,800 shares of LLY stock, worth $1.46 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,800
Previous 1,800 -0.0%
Holding current value
$1.46 Million
Previous $1.59 Million 12.86%
% of portfolio
0.11%
Previous 0.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 10, 2023

SELL
$321.55 - $374.67 $17,042 - $19,857
-53 Reduced 2.86%
1,800 $0
Q1 2022

Apr 11, 2022

SELL
$234.69 - $291.66 $1,642 - $2,041
-7 Reduced 0.38%
1,853 $531,000
Q4 2021

Mar 17, 2022

SELL
$224.85 - $279.04 $771,685 - $957,665
-3,432 Reduced 64.85%
1,860 $514,000
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $773,827 - $952,303
3,492 Added 194.0%
5,292 $430,000
Q2 2021

Aug 02, 2021

BUY
$180.55 - $233.54 $324,990 - $420,372
1,800 New
1,800 $413,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $771B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Lbmc Investment Advisors, LLC Portfolio

Follow Lbmc Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lbmc Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lbmc Investment Advisors, LLC with notifications on news.